K4 Elite logo K4 Elite
Home / Peptide Library / Chonluten
Emerging Research

Chonluten

Inflammation & Immunity · ['Chonluten (Cytomax)', 'Bronchial/lung peptide bioregulator', 'T-34 peptide (cited analog)']

A peptide-complex bioregulator derived from bronchial and lung tissue, studied in Russian literature for proposed effects on respiratory-tissue function and mucosal immunity.

🔬 Research use only — not for human or veterinary use. K4 Elite does not provide dosing instructions.
Research Level
Emerging Research
Browse the store →
🧬

Chonluten is a 'cytomax' peptide bioregulator in the Khavinson tradition, described as a complex of short peptides derived from bronchial and lung tissue. Some sources associate it with a cited synthetic tripeptide analog (Glu-Asp-Gly, referenced as T-34), though the commercial preparation is generally described as a tissue-derived complex.

Within the tissue-specific bioregulator framework, Chonluten is linked to the respiratory system and to mucosal tissue. Because the commercial complex is not a single characterized molecule and sources are inconsistent, no verified structure or PubChem identifier is established.

Molecular fields are therefore left blank. The summary below reflects available scientific literature for reference purposes only.

The Khavinson-school hypothesis proposes that short respiratory-tissue peptides regulate tissue-specific gene expression, with reported laboratory effects on bronchial epithelium and antioxidant and inflammatory markers in animal models.

These mechanistic accounts originate largely from the developing research group and remain hypotheses under investigation rather than independently confirmed pathways.

  • Bronchial and lung tissue function in animal models
  • Mucosal immunity and airway inflammation research
  • Peptide bioregulation and tissue-specific gene-expression hypotheses
  • Antioxidant and cytoprotective activity investigations
  • Geroprotective peptide research in respiratory-aging models
📋 How published studies were conducted — a research reference summarizing study designs from the literature. This is not usage, dosing, or administration guidance. K4 Elite does not provide dosing instructions; determining any research protocol is the sole responsibility of the qualified researcher.

Khavinson and colleagues have reported animal and cell studies of bronchial peptide preparations, describing effects on airway epithelial markers, antioxidant parameters, and inflammatory measures. These are summarized strictly as published exploratory findings from a single research school.

Review work situates Chonluten within the cytomax bioregulator framework alongside other tissue peptides, describing proposed cytoprotective activity observed in laboratory settings rather than in large controlled independent trials.

Combinations examined in the research literature. Descriptive only — not a recommendation to combine compounds.

CortagenCompatible
Another Khavinson tissue bioregulator studied within the same peptide framework.
Anti-inflammatory small moleculesNeutral
Overlapping airway-inflammation research themes; interactions are not characterized in study data.
Thymalin / immune peptidesCompatible
Related peptide bioregulators studied in overlapping immunity research programs.
Antioxidant compoundsNeutral
Shared antioxidant research themes; combined effects are not well described.
  1. Khavinson VK. Peptides and Ageing. Neuro Endocrinol Lett 2002
  2. Anisimov VN, Khavinson VK. Peptide Bioregulation of Aging: Results and Prospects. Biogerontology 2010
  3. Khavinson VK et al. Peptide Regulation of Gene Expression: A Systematic Review. Molecules 2021
What is Chonluten?
It is a bronchial- and lung-tissue-derived peptide complex from the Khavinson family of bioregulators, studied for proposed effects on respiratory tissue and mucosal immunity.
Why are molecular fields blank?
Chonluten is described as a multi-peptide complex rather than a single defined molecule, and no verified PubChem identifier is consistently reported, so no molecular data is fabricated here.
How strong is the evidence base?
Most published work originates from a single research school, so Chonluten is classified as an emerging-research compound pending broader independent validation.
What tissue is it associated with?
It is associated in the literature with bronchial and lung tissue and with respiratory mucosal-immunity research.
Is this material for human or veterinary use?
No. It is supplied strictly as a research-use-only reference material and is not intended for human consumption, medical treatment, or veterinary application.
Disclaimer: This profile summarizes published preclinical and laboratory research for reference only. It is not medical advice and makes no claim of safety or efficacy in humans. Determining any research protocol is the sole responsibility of the qualified researcher. Products are sold strictly for in-vitro research and have not been evaluated by the FDA.